TELA Bio, Inc. revenue for the last year amounted to 58.45 M USD, the most of which — 58.45 M USD — came from its highest performing source at the moment, Soft-tissue Reconstruction Solutions, the year earlier bringing 41.42 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought TELA Bio, Inc. 58.45 M USD, and the year before that — 41.42 M USD.